Krebs Biochemicals & Industries Limited

Equities

KREBSBIO

INE268B01013

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:50 2024-04-26 am EDT 5-day change 1st Jan Change
73.01 INR +2.61% Intraday chart for Krebs Biochemicals & Industries Limited +3.34% -6.80%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Krebs Biochemicals & Industries Limited Announces Resignation of Keyur Doshi as Company Secretary, Compliance Officer CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Krebs Biochemicals & Industries Limited Appoints Keyur Doshi as Company Secretary, Compliance Officer CI
Andhra Pradesh Pollution Control Board Orders Production Halt at Krebs Biochemicals Plant MT
Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Krebs Biochemicals & Industries Limited Approves Resignation of Mr. Pabitrakumar Kalipada Bhattacharya as Managing Director CI
Krebs Biochemicals Limited Announces Executive Changes, Effective 10 August 2023 CI
Krebs Biochemicals Trims Net Loss in Fiscal Q4 MT
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Krebs Biochemicals Names New CFO MT
Krebs Biochemicals & Industries Limited Approves Appointment of Rohit Taparia as Company Secretary and Compliance Officer CI
Krebs Biochemicals & Industries Limited Approves CFO Changes CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Krebs Biochemicals & Industries Limited Auditor Raises 'Going Concern' Doubt CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Taruni Banda Resigns as Company Secretary and Compliance Officer of Krebs Biochemicals & Industries Limited, Effective from August 6, 2022 CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Krebs Biochemicals & Industries Limited announced that it has received INR 1 billion in funding from Ipca Laboratories Limited CI
Krebs Biochemicals & Industries Limited Appoints Jitendra Shah as Additional Director, Non-Executive Category CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Krebs Biochemicals & Industries Limited to Consider Resignation of E J Babu as Non-Executive Director CI
Krebs Biochemicals & Industries Limited announced that it expects to receive INR 1 billion in funding from Ipca Laboratories Limited CI
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Chart Krebs Biochemicals & Industries Limited
More charts
Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Company’s pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.
More about the company
  1. Stock Market
  2. Equities
  3. KREBSBIO Stock
  4. News Krebs Biochemicals & Industries Limited
  5. Andhra Pradesh Pollution Control Board Orders Production Halt at Krebs Biochemicals Plant